Dalton Pharma News

Dalton Pharma Services Wins 2018 CMO Leadership Awards

TORONTO: (MAY 26, 2018) Dalton Pharma Services, a leading North American pharmaceutical cGMP contract manufacturing company, is excited to announce that it has won for a third year in the row the Life Sciences Leader-CMO Leadership Award, which recognizes the highest quality contract manufacturing organizations as chosen by real customers, in five core categories: Reliability, Capabilities, Expertise, Compatibility and Development. Dalton was acknowledged as a winner in Expertise, Quality & Reliability. 

“Life Science Leader CMO Leadership Awards, in its seventh year now, congratulates all the winners in recognition of the highest level of accomplishment in the drug development and manufacturing industry,” says Louis Garguilo, Chief Editor, Life Science Leader magazine and Outsourced Pharma. “These awards are even more meaningful as the recipients are evaluated only by the customers they have worked with.”

The 2018 awards CMO Leadership awards were conducted by Life Science Connect and Industry Standard Research (ISR) to determine the award recipients. More than 110 CMOs were evaluated on 23 performance metrics in ISR's annual Contract Manufacturing Quality Benchmarking survey. Respondents only evaluated companies they worked with in the past 18 months. This level of qualification ensures that ratings come from actual involvement with contract manufacturers and clear experiential data. For further details, please visit http://www.cmoleadershipawards.com.

“We are extremely honoured to receive this prestigious award for a third consecutive year from our customers,” said Peter Pekos, CEO and President, Dalton Pharma Services. “Development of novel medicines requires a highly interdisciplinary and technologically sophisticated group of professionals. Delivering for our clients demands a team with deep understanding of science and regulatory compliance along with an innovative mindset. We are grateful to our employees for the exceptional services that they provide and the award-winning growth and innovation that results.”

About Dalton Pharma Service 

Dalton Chemical Laboratories Inc. o/a Dalton Pharma Services is a Health Canada Establishment licensed and FDA registered cGMP contract service provider of integrated chemistry, drug development and manufacturing services to the pharmaceutical and biotechnology industries. We bring over 30 years of experience to our client's projects and emphasize on quality, speed and flexibility.

Dalton can accelerate your drug development program by integrating process development,cGMP API manufacturing, cGMP sterile fill/finish and solid finished dose manufacturing, all at a single location. 

Our CMO 2016, 2017 and 2018 Leadership Awards in the categories of Quality, Reliability, Capabilities, Expertise, Compatibility and Development from Life Science Leader reflect our ongoing commitment to our clients, peers and the business community. 

Dalton has also officially been re-certified as “A Great Place to Work” for a third consecutive year in 2018 as one of the best Canadian companies to work for, by a global research and consulting firm Great Place to Work®.

To learn more about Dalton and our full range of in-house services please visit https://www.dalton.com
Peter Pekos 
President & CEO 
Dalton Pharma Services 
349 Wildcat Road 
Toronto, Ontario 
Tel: 416-661-2102